Gene · 2829
XCR1: X-C motif chemokine receptor 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. XCR1: X-C motif chemokine receptor 1. Genes, record 2829. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2829
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P46094 | Chemokine XC receptor 1 | 333 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents78
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4803546 A1 | 2026-09-09 | 39 | P46094 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 40991 | P46094 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 40993 | P46094 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 4248 | P46094 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 252 | P46094 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 5273 | P46094 | Espacenet |
| JP 2025524662 A | 2025-07-30 | 7 | P46094 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 5273 | P46094 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 4248 | P46094 | Espacenet |
| EP 4555326 A2 | 2025-05-21 | 7 | P46094 | Espacenet |
1 to 10 of 78
See all 78 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,173
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | XCR1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 8 | 2025 |
| P30CA091842 | Cancer Center Support Grant | 8 | 2025 |
| U19AI128949 | Human anti-viral immune responses in tissues and circulation | 6 | 2025 |
| R37AI058072 | Structural Basis for Chemokine Function | 5 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 4 | 2025 |
| P30DK043351 | Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital | 4 | 2025 |
| R37AI072571 | Molecular Control of Plasmacytoid Dendritic Cell Development and Function | 4 | 2025 |
| UL1TR002345 | Washington University Institute of Clinical and Translational Sciences | 4 | 2025 |
| I01BX000656 | Immunoregulatory Mechanisms to Combat CNS Pathology During Infection | 3 | 2025 |
| P30CA016056 | Roswell Park Cancer Center Support Grant | 3 | 2025 |
1 to 10 of 1,173Source NIH's project files
See all 1,173 nih grantsPapers1,709
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Bile Acid Signaling Axis: Deciphering the Roles of FXR and TGR5 in Hepatic Steatosis, Fibrosis, and Cancer. | Pharmacol Res Perspect | 2026 | 42811458 | PubTator, text mining | PubMed |
| Canonical and isomiR products of miR-142 enhance dendritic cell reprogramming. | Cell Rep | 2026 | 42593968 | PubTator, text mining | PubMed |
| Association of chemokine and chemokine receptor gene variants with occurrence of multiple primary melanoma. | Melanoma Res | 2026 | 42550086 | PubTator, text mining | PubMed |
Personalized tumor-loaded monocyte-derived dendritic cell vaccination in combination with atezolizumab as maintenance treatment in extensive-stage small cell lung cancer (ES-SCLC): phase Ib-II VENEZOLUNG trial. | J Immunother Cancer | 2026 | 42498486 | PubTator, text mining | PubMed |
| SBRT embedded in low-dose RT plus αPD-1 (immuno-EclipseRT, iERT) elicits CD8+ T cell immunity against bulky tumors via an IFN-I/NK/DC axis. | Nat Commun | 2026 | 42420294 | PubTator, text mining | PubMed |
| dNK3 cells in normal pregnancy and recurrent pregnancy loss: from molecular identity to functional imbalance. | Front Immunol | 2026 | 42212143 | PubTator, text mining | PubMed |
| A cDC1-NK/T-Malignant Cell Circuit Drives Immunogenic Remodeling Under PD-1 Blockade in Gastric Cancer. | Cancer Sci | 2026 | 42166535 | PubTator, text mining | PubMed |
| Shared autonomous HERV loci transcription identifies a unique circulating CD14+-xCR1+ mononuclear cell phenotype in a patient group with post-acute sequelae of COVID-19. | PLoS One | 2026 | 42154742 | PubTator, text mining | PubMed |
| Homeostatic mature dendritic cells instruct fibroblast specialization via Notch2 signaling to establish T cell niches. | Immunity | 2026 | 42030954 | PubTator, text mining | PubMed |
| Dual-chemokine-armed oncolytic Senecavirus A co-recruits cDC1 and CXCR3+ T cells to convert 'cold' melanoma and drive durable regression. | J Immunother Cancer | 2026 | 41916730 | PubTator, text mining | PubMed |
1 to 10 of 1,709
See all 1,709 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/2829
GET https://conductscience.org/api/genes/v1/2829/patents?page=2